Company Profiles

driven by the PitchBook Platform

Airway Therapeutics

Description

Developer of acute and chronic lung disease therapies created to redefine protein therapeutics development for pediatrics. The company's lead product, AT-100, is a recombinant form of human surfactant protein-D, absent from current therapies, that changes the properties of the commercial lung surfactant, converting it to a more natural state in the lungs so the body can better use it, thus improving lung function.

2011

Founded

PRIVATE

Status

Early Stage VC

Latest Deal Type

$6.3M

Latest Deal Amount

$12.1M

Total Amount Raised

4

Investors

Description

Developer of acute and chronic lung disease therapies created to redefine protein therapeutics development for pediatrics. The company's lead product, AT-100, is a recombinant form of human surfactant protein-D, absent from current therapies, that changes the properties of the commercial lung surfactant, converting it to a more natural state in the lungs so the body can better use it, thus improving lung function.

Website:

www.airwaytherapeutics.com

Ownership Status

Privately held (backing)

Financing Status

Venture Capital-Backed

Primary Industry

Biotechnology

Other Industries

Drug Discovery

Primary Office

11804 Conrey Road Suite 175 Cincinnati, OH 45249United States +1 (513) 770-9630
Request a free trial to the PitchBook Platform
You're viewing a free company profile from the PitchBook Platform. To explore Airway Therapeutics's full profile, request a free trial.

Airway Therapeutics Valuation and Funding

Request access
Deal TypeDateAmountRaised to DatePost-ValStatusStage

Airway Therapeutics Investors (4)

Request access
Investor NameInvestor TypeHoldingInvestor SinceParticipating RoundsBoard
Seat
Contact
Info
Cincinnati Children's Hospital Medical CenterNot-For-Profit Venture CapitalMinority000 0000000 0000
CincyTechVenture CapitalMinority000 0000000 0000
KTECH CapitalVenture CapitalMinority000 0000000 0000
Queen City AngelsAngel GroupMinority000 0000000 0000
Cincinnati Children's Hospital Medical Center Not-For-Profit Venture Capital
CincyTech Venture Capital
KTECH Capital Venture Capital
Queen City Angels Angel Group

Airway Therapeutics Executive Team (4)

NameTitleBoard
Seat
Contact
Info
Marc Salzberg MDChief Executive Officer, President & Board Member
Andrew LevyChief Financial Officer
Jan Rosenbaum Ph.DChief Scientific Officer
Paul RemsenVice President of Manufacturing
Marc Salzberg MD Chief Executive Officer, President & Board Member
Andrew Levy Chief Financial Officer
Jan Rosenbaum Ph.D Chief Scientific Officer
Paul Remsen Vice President of Manufacturing

Airway Therapeutics Board Members (5)

NameRepresentingRoleSinceContact
Info
Jennifer DauerCincyTechBoard Member000 0000
John Rice Ph.DCincyTechAdvisor & Director of Life Sciences000 0000
Marc Salzberg MDAirway TherapeuticsChief Executive Officer, President & Board Member000 0000
Michael VenerableCincyTechManaging Director & Chief Investment Officer000 0000
Nicole Robinson Ph.DSelfBoard Member000 0000
Jennifer Dauer Board Member CincyTech
John Rice Ph.D Advisor & Director of Life Sciences CincyTech
Marc Salzberg MD Chief Executive Officer, President & Board Member Airway Therapeutics
Michael Venerable Managing Director & Chief Investment Officer CincyTech
Nicole Robinson Ph.D Board Member Self
Request full access to PitchBook